Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU).
Ah-Thiane L, Sargos P, Chapet O, Jolicoeur M, Terlizzi M, Salembier C, Boustani J, Prevost C, Gaudioz S, Derashodian T, Palumbo S, De Hertogh O, Créhange G, Zilli T, Supiot S.
Ah-Thiane L, et al. Among authors: prevost c.
Cancer Treat Rev. 2023 Nov;120:102626. doi: 10.1016/j.ctrv.2023.102626. Epub 2023 Sep 16.
Cancer Treat Rev. 2023.
PMID: 37734178
Review.